---
configuration: 
  locale: en-US
  dynamo: mock

--- 
- test: NavigateMutationsIntent_S 
- NavigateMutationsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "ovarian cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "Among Ovarian serous cystadenocarcinoma patients, TP53 and TTN are the top 2 mutated genes found in 70 percent and 22 percent of the patients respectively."
  - response.shouldEndSession: false

--- 
- test: NavigateMutationsIntent_G
- NavigateMutationsIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 mutations are found in 31 out of 33 cancer types. It is most mutated in Ovarian serous cystadenocarcinoma at 70 percent followed by Lung squamous cell carcinoma at 68 percent."
  - response.shouldEndSession: false

--- 
- test: NavigateMutationsIntent_Error
- NavigateMutationsIntent:
  - response.outputSpeech.ssml: "I need to know a gene name first. What gene are you interested in?"
  - response.shouldEndSession: false

--- 
- test: NavigateMutationsIntent_GS
- NavigateMutationsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 mutations are found in 30 percent of Breast invasive carcinoma patients with 53 amino acid residues recurrently mutated."
  - response.shouldEndSession: false

--- 
- test: NavigateMutationDomainsIntent_G
- NavigateMutationDomainsIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 mutations are found in 31 out of 33 cancer types. It is most mutated in Ovarian serous cystadenocarcinoma at 70 percent followed by Lung squamous cell carcinoma at 68 percent."
  - response.shouldEndSession: false

--- 
- test: NavigateMutationDomainsIntent_GS
- NavigateMutationsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 mutations are found in 30 percent of Breast invasive carcinoma patients with 53 amino acid residues recurrently mutated."
  - response.shouldEndSession: false

--- 
- test: NavigateMutationDomainsIntent_Error
- NavigateMutationDomainsIntent:
  - response.outputSpeech.ssml: "I need to know a gene name first. What gene are you interested in?"
  - response.shouldEndSession: false

--- 
- test: NavigateIndelsIntent_G
- NavigateIndelsIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 indels are found in 26 out of 33 cancer types. It has most indels in Esophageal carcinoma at 12.1 percent followed by Ovarian serous cystadenocarcinoma at 11.7 percent."
  - response.shouldEndSession: false

--- 
- test: NavigateIndelsIntent_S 
- NavigateIndelsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "ovarian cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "Among Ovarian serous cystadenocarcinoma patients, TP53 and NF1 are the top 2 genes with indels found in 11.7 percent and 1.8 percent of the patients respectively."
  - response.shouldEndSession: false

--- 
- test: NavigateIndelsIntent_GS
- NavigateIndelsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 indels are found in 5.7 percent of Breast invasive carcinoma patients with 6 amino acid residues recurrently mutated."
  - response.shouldEndSession: false

--- 
- test: NavigateIndelsIntent_Error
- NavigateIndelsIntent:
  - response.outputSpeech.ssml: "I need to know a gene name first. What gene are you interested in?"
  - response.shouldEndSession: false

--- 
- test: NavigateIndelDomainsIntent_G
- NavigateIndelDomainsIntent:
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "TP53 indels are found in 26 out of 33 cancer types. It has most indels in Esophageal carcinoma at 12.1 percent followed by Ovarian serous cystadenocarcinoma at 11.7 percent."
  - response.shouldEndSession: false

--- 
- test: NavigateIndelDomainsIntent_S 
- NavigateIndelDomainsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "ovarian cancer"
        confirmationStatus: "NONE"
  - response.outputSpeech.ssml: "Among Ovarian serous cystadenocarcinoma patients, TP53 and NF1 are the top 2 genes with indels found in 11.7 percent and 1.8 percent of the patients respectively."
  - response.shouldEndSession: false

--- 
- test: NavigateIndelDomainsIntent_GS
- NavigateIndelDomainsIntent:
  - request.request.intent.slots:
      query:
        name: "query"
        value: "breast cancer"
        confirmationStatus: "NONE"
  - request.session.attributes:
      MELVIN.STATE:
        gene_name: "TP53"
  - response.outputSpeech.ssml: "P53 DNA-binding domain and none are the most affected domains containing 75 percent and 17.9 percent of indels respectively."
  - response.shouldEndSession: false

--- 
- test: NavigateIndelDomainsIntent_Error
- NavigateIndelDomainsIntent:
  - response.outputSpeech.ssml: "I need to know a gene name first. What gene are you interested in?"
  - response.shouldEndSession: false